3647 results for «604»
3647 results
Challenging STEMI scenarios: part 2
07 Dec 2023 – From GulfPCR-GIM 2023
In this session, delve into intricate STEMI cases, featuring presentations on the challenges of primary PCI for left main, the significance of IVUS in STEMI patients during primary PCI, a compelling exploration of myocardial infarction in an anomalous coronary artery, and much more!
Tailored approaches to complex bifurcation PCI: part 2
07 Dec 2023 – From GulfPCR-GIM 2023
Consult this session to discover various complex PCI bifurcation cases, and learn more about the step by step approach on how to treat an ostial LAD lesion, and relevant procedures, such as the cutting balloon angioplasty, CABG or the trifurctional intervention.
Complex left main PCI: ancillary tools for safer interventions
07 Dec 2023 – From GulfPCR-GIM 2023
Consult this session to discover complex left main PCI cases, such as a severe stenosis in the distal left main bifurcation and differentiating atherosclerotic lesions from catheter-induced vasospasm, explore effective techniques such as imaging-guided optimisation for complex angioplasty, and more!
When complications storm through the cathlab: part 3
07 Dec 2023 – From GulfPCR-GIM 2023
These slides focus on complications that may occur during PCI in the cathlab. Through the lens of this case, be prepared about what type of complications one might face during PCI, and get updates on the latest guidelines and tools developed for emergencies.
Which AF patients may benefit from LAA closure?
02 Jul 2026
Martin Bergmann reviews the evolving evidence for LAAC, examining how recent landmark trials such as OPTION, CLOSURE‑AF and CHAMPION‑AF are reshaping patient selection and expanding the role of LAAC across a broader spectrum of patients with atrial fibrillation.
Author
Future directions of drug-coated balloon angioplasty
06 Feb 2025
Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.
Author
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
